by jeremy | Mar 24, 2023 | Healthcare
Frost & Sullivan Frost & Sullivan Removal of Problematic Host Cell Proteins—What’s Next? Exploding demand, increasing FDA drug approvals, and promising pipelines continue to invite significant investment in the biopharmaceutical industry. The call to make drugs...
by jeremy | Mar 9, 2023 | Healthcare
Frost & Sullivan Frost & Sullivan Push & Pull: The Duality of Modern Clinical Trials Clinical trials and research have mostly taken place on-site, where participants must travel to a central location, often multiple times, creating logistical issues. With...
by Michelle Hernandez | Mar 3, 2023 | Healthcare
Frost & Sullivan Frost & Sullivan Gene Therapy Process Development 2.0 – What’s Next? Gene therapy continues to experience explosive growth driven by the development of better assays, more-frequent outsourcing to contract development and manufacturing...
by Michelle Hernandez | Mar 3, 2023 | Healthcare
Frost & Sullivan Frost & Sullivan Contaminant Removal Strategies for Cell and Gene Therapies The Cell and Gene Therapies (CGT) manufacturing space is one of significant growth and appreciable change. The compression of the customer value chain is a major driver when...
by Michelle Hernandez | Jan 20, 2023 | Healthcare
Details Participants FAQ RSVP Frost & Sullivan — Virtual Think Tank — Overcoming Challenges in Medical Devices Design and Manufacturing Moderator: Charlie WhelanSenior Vice President Consulting Frost & Sullivan’s Healthcare Group Follow...
by Michelle Hernandez | Jan 20, 2023 | Healthcare
Frost & Sullivan Re-Examining Radiology: A look to the future in advancing healthcare COVID-19 was a catalyst for aspects of the healthcare market’s digital transformation strategies, showcasing gaps and needs in some areas while rapidly advancing others. The initial...
Recent Comments